Barbara E. Mahon, MD

Adjunct Professor, Epidemiology

Barbara Mahon
715 Albany St Talbot Building


Dr. Mahon received her MD and clinical training in pediatrics from the University of California, San Francisco and her MPH from the University of California, Berkeley. She trained in CDC’s Epidemic Intelligence Service (EIS). Dr. Mahon is deputy chief of the Enteric Diseases Epidemiology and Surveillance Branch at the Centers for Disease Control and Prevention (CDC). The branch is responsible for national surveillance for enteric diseases. It conducts epidemiologic studies of the burden, trends, and food source attribution of foodborne diseases caused by Listeria , Salmonella, and E. coli O157, among other pathogens. The branch’s work also focuses on vulnerable populations, including older adults, young children, and other groups, with the goal of creating knowledge needed to protect people by preventing disease. Dr. Mahon has a broad background in infectious disease epidemiology, having worked on foodborne diseases, vaccine-preventable diseases, and sexually transmitted diseases in academic and industry positions as well as in government.

Other Positions

  • Adjunct Assistant Professor, General Pediatrics, Pediatrics, Boston University Chobanian & Avedisian School of Medicine


  • University of California San Francisco, MD
  • University of California, Berkeley, MPH
  • Harvard University, AB


  • Published on 8/25/2023

    Jones JM, Fleming-Dutra KE, Prill MM, Roper LE, Brooks O, Sánchez PJ, Kotton CN, Mahon BE, Meyer S, Long SS, McMorrow ML. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 25; 72(34):920-925. PMID: 37616235.

    Read at: PubMed
  • Published on 5/12/2023

    Silk BJ, Scobie HM, Duck WM, Palmer T, Ahmad FB, Binder AM, Cisewski JA, Kroop S, Soetebier K, Park M, Kite-Powell A, Cool A, Connelly E, Dietz S, Kirby AE, Hartnett K, Johnston J, Khan D, Stokley S, Paden CR, Sheppard M, Sutton P, Razzaghi H, Anderson RN, Thornburg N, Meyer S, Womack C, Weakland AP, McMorrow M, Broeker LR, Winn A, Hall AJ, Jackson B, Mahon BE, Ritchey MD. COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023. MMWR Morb Mortal Wkly Rep. 2023 May 12; 72(19):523-528. PMID: 37167154.

    Read at: PubMed
  • Published on 10/5/2022

    Simon JK, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ, Liu K, Hartzel J, Coller BG, Welebob C, Hanson ME, Grais RF. Immunogenicity of rVSV?G-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials. Vaccine. 2022 Nov 02; 40(46):6599-6606. PMID: 36208978.

    Read at: PubMed
  • Published on 8/19/2022

    Massetti GM, Jackson BR, Brooks JT, Perrine CG, Reott E, Hall AJ, Lubar D, Williams IT, Ritchey MD, Patel P, Liburd LC, Mahon BE. Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems - United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 19; 71(33):1057-1064. PMID: 35980866.

    Read at: PubMed
  • Published on 6/24/2022

    Gold JAW, Kelleher J, Magid J, Jackson BR, Pennini ME, Kushner D, Weston EJ, Rasulnia B, Kuwabara S, Bennett K, Mahon BE, Patel A, Auerbach J. Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 24; 71(25):825-829. PMID: 35737571.

    Read at: PubMed
  • Published on 1/14/2022

    Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, Pavkov ME, Rolka DB, Wiltz JL, Bull-Otterson L, Gray S, Boehmer TK, Gundlapalli AV, Siegel DA, Kompaniyets L, Goodman AB, Mahon BE, Tauxe RV, Remley K, Saydah S. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):59-65. PMID: 35025851.

    Read at: PubMed
  • Published on 1/11/2022

    Cohn AC, Mahon BE, Walensky RP. One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality. JAMA. 2022 Jan 11; 327(2):119-120. PMID: 34932067.

    Read at: PubMed
  • Published on 12/15/2021

    Dolan SB, Mahon BE, Dowell SF, Zaidi A. Toward Understanding Death. Clin Infect Dis. 2021 12 15; 73(Suppl_5):S341-S342. PMID: 34910167.

    Read at: PubMed
  • Published on 12/1/2021

    Mahon BE, Simon J, Widdowson MA, Samai M, Rogier E, Legardy-Williams J, Liu K, Schiffer J, Lange J, DeByle C, Pinner R, Schuchat A, Slutsker L, Goldstein S. Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein. J Infect Dis. 2021 12 01; 224(11):1907-1915. PMID: 34013349.

    Read at: PubMed
  • Published on 5/14/2021

    Morgan OW, Aguilera X, Ammon A, Amuasi J, Fall IS, Frieden T, Heymann D, Ihekweazu C, Jeong EK, Leung GM, Mahon B, Nkengasong J, Qamar FN, Schuchat A, Wieler LH, Dowell SF. Disease surveillance for the COVID-19 era: time for bold changes. Lancet. 2021 06 19; 397(10292):2317-2319. PMID: 34000258.

    Read at: PubMed

View 111 more publications: View full profile at BUMC

View all profiles